ERIN PEARSON
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Acute Care NASHVILLE, TN NPI 1629658232
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Acute Care TN ABBVIE INC. All categories
General Payments — all program years on this page
$2,536.46
- Category: General Payments
- Program years: PY2023–2024
- Record count: 71
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $2,223.73 across 58 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,400.74 | 53 |
| Consulting Fee | $640.00 | 3 |
| Education | $182.99 | 2 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $397.79 | 9 |
| Genentech USA, Inc. | $396.31 | 2 |
| PFIZER INC. | $205.00 | 5 |
| Janssen Biotech, Inc. | $156.66 | 2 |
| Janssen Scientific Affairs, LLC | $115.00 | 1 |
| Ipsen Biopharmaceuticals, Inc | $97.33 | 3 |
| Celgene Corporation | $90.07 | 4 |
| Daiichi Sankyo Inc. | $89.55 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $87.40 | 4 |
| Acerta Pharma LLC | $86.50 | 3 |
| ADC Therapeutics America, Inc. | $85.66 | 4 |
| GENZYME CORPORATION | $66.06 | 2 |
| Incyte Corporation | $54.07 | 2 |
| SERVIER PHARMACEUTICALS LLC | $47.25 | 2 |
| TAIHO ONCOLOGY, INC. | $37.53 | 2 |
| JAZZ PHARMACEUTICALS INC. | $31.55 | 1 |
| Merck Sharp & Dohme Corporation | $30.11 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $25.46 | 1 |
| Genmab U.S., Inc. | $25.44 | 1 |
| PharmaEssentia USA Corporation | $22.78 | 1 |
| SOBI, INC | $20.43 | 1 |
| BeiGene USA, Inc. | $20.39 | 1 |
| Lilly USA, LLC | $19.18 | 1 |
| Pharmacosmos Therapeutics Inc. | $16.21 | 1 |
By program year
Records — PY2024 (58)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.